...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Re: Report of Exempt Distribution....

I find that happens to me on these "Report of Exempt Distribution" filings when I access SEDAR through Chrome but if I then do it through Internet Explorer, it will load. The reports on these don't tell you any more than what G1945V gave you on Stockhouse. You can only guess who the USA ones were sold to. 

New Message
Please login to post a reply